- Assistant Professor, CWRU School of Medicine
Lee M. Ocuin, MD, joined University Hospitals as a faculty surgeon in the Division of Surgical Oncology in April 2021. Specializing in hepatopancreatobiliary surgery, Dr. Ocuin is also an assistant professor of surgery. He graduated cum laude from Brandeis University (Waltham, Massachusetts) in 2002, where he earned a Bachelor of Science in Biochemistry and Biology. He obtained his medical degree from Tufts University School of Medicine (Boston, Massachusetts) in 2006 and was elected to the Alpha Omega Alpha Honor Medical Society.
Dr. Ocuin completed his General Surgery residency at Emory University School of Medicine (Atlanta, Georgia) in 2014. During his time as a resident, he completed a Postdoctoral Research Fellowship in the Department of Surgery, Hepatopancreatobiliary Section, at Memorial Sloan Kettering Cancer Center (New York, New York). Between 2014 and 2017, Dr. Ocuin also completed a fellowship in Complex General Surgical Oncology at the University of Pittsburgh Medical Center (Pittsburgh, Pennsylvania) and a fellowship in Hepatopancreatobiliary Surgery at Mayo Clinic (Rochester, Minnesota).
Prior to joining UH and Case Western Reserve University School of Medicine, Dr. Ocuin was the Site-Based Medical Director of the Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery at Atrium Health – Cabarrus. He is the recipient of a number of honors and awards, most recently the Atrium Health – Cabarrus, Physician of the Quarter in 2019; and the Emory University School of Medicine, Department of Surgery, ABSITE Award, which he won in 2012, 2013 and 2014. He was elected as Fellow of the American College of Surgeons in 2020. Dr. Ocuin is a member of various professional societies, among them The Americas Hepato-Pancreato-Biliary Association, The American College of Surgeons, The Society for Surgery of the Alimentary Tract, The Society of Surgical Oncology, and The American Society of Clinical Oncology. In addition, he serves as a peer reviewer for such medical journals as Annals of Surgery, Journal of Surgical Oncology, Journal of Surgical Research, Journal of Gastrointestinal Surgery, HPB, and Surgery.
- Abdominal Sarcoma
- Bile Duct Cancers
- Bile Duct Injuries
- Bile Duct Strictures
- Chronic Pancreatitis
- Gallbladder Cancer
- Hilar Cholangiocarcinoma
- Intrahepatic Cholangiocarcinoma
- Klatskin Tumors
- Liver Cancers
- Liver Metastases
- Metastatic Colorectal Cancer
- Metastatic Neuroendocrine Tumor
- Pancreatic Cancer
- Pancreatic Cysts
- Pancreatic Neuroendocrine Tumors
Certifications & Memberships
- Complex General Surgical Oncology - American Board of Surgery
- Surgery - American Board of Surgery
Fellowship | Robotic Hepatopancreatobiliary Surgery
Robotic Hepatopancreatobiliary Surgery - Atrium Health Carolinas Medical Center (2017 - 2017)
Fellowship | Hepato-Pancreato-Biliary Surgery
Hepato-Pancreato-Biliary Surgery - Mayo Clinic (2016 - 2017)
Fellowship | Surgical Oncology
Surgical Oncology - University Of Pittsburgh Medical Center UPMC (2014 - 2016)
Research Fellowship | Hepato-Pancreato-Biliary Surgery
Hepato-Pancreato-Biliary Surgery - Memorial Sloan-Kettering Cancer Center (2008 - 2011)
Residency | General Surgery
General Surgery - Emory University Hospital (2006 - 2014)
Tufts University School Of Medicine (2006)
Brandeis University (2002)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Lee Ocuin did not disclose any Outside Relationships with Industry.